Competitive CDMRP award funds preclinical programs against two cryptic cell-surface targets discovered directly in patient tumors using the company's AI-powered RyboCypher™ platform and CypherAtlas™ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results